Subject flow diagram. by Joseph Rabin (7399436)

Subjects:

Quantitative 16S rRNA Gene Amplicon Sequencing for Comprehensive Pathogenic Bacterial Tracking in a Municipal Wastewater Treatment Plant by Rasindu Galagoda (14776521)

“…The total pathogen concentrations were gradually decreased from 6.8 ± 4.9 × 10⁷ copies/mL in the influent to 1.6 ± 1.4 × 10⁵ copies/mL in the effluent. …”

Quantitative 16S rRNA Gene Amplicon Sequencing for Comprehensive Pathogenic Bacterial Tracking in a Municipal Wastewater Treatment Plant by Rasindu Galagoda (14776521)

“…The total pathogen concentrations were gradually decreased from 6.8 ± 4.9 × 10⁷ copies/mL in the influent to 1.6 ± 1.4 × 10⁵ copies/mL in the effluent. …”

Quantitative 16S rRNA Gene Amplicon Sequencing for Comprehensive Pathogenic Bacterial Tracking in a Municipal Wastewater Treatment Plant by Rasindu Galagoda (14776521)

“…The total pathogen concentrations were gradually decreased from 6.8 ± 4.9 × 10⁷ copies/mL in the influent to 1.6 ± 1.4 × 10⁵ copies/mL in the effluent. …”

Quantitative 16S rRNA Gene Amplicon Sequencing for Comprehensive Pathogenic Bacterial Tracking in a Municipal Wastewater Treatment Plant by Rasindu Galagoda (14776521)

“…The total pathogen concentrations were gradually decreased from 6.8 ± 4.9 × 10⁷ copies/mL in the influent to 1.6 ± 1.4 × 10⁵ copies/mL in the effluent. …”

Quantitative 16S rRNA Gene Amplicon Sequencing for Comprehensive Pathogenic Bacterial Tracking in a Municipal Wastewater Treatment Plant by Rasindu Galagoda (14776521)

“…The total pathogen concentrations were gradually decreased from 6.8 ± 4.9 × 10⁷ copies/mL in the influent to 1.6 ± 1.4 × 10⁵ copies/mL in the effluent. …”

Quantitative 16S rRNA Gene Amplicon Sequencing for Comprehensive Pathogenic Bacterial Tracking in a Municipal Wastewater Treatment Plant by Rasindu Galagoda (14776521)

“…The total pathogen concentrations were gradually decreased from 6.8 ± 4.9 × 10⁷ copies/mL in the influent to 1.6 ± 1.4 × 10⁵ copies/mL in the effluent. …”

Inadequate riparian zone use directly decreases water quality of a low-order urban stream in southern Brazil by Enzo Luigi Crisigiovanni (8709570)

Detection of oxidized proteins by oxyblot in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. by Patrick Mordel (17020879)

Fe limitation decreases transcriptional regulation over the diel cycle in the model diatom <i>Thalassiosira pseudonana</i> by Johanna A. L. Goldman (7372724)

Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial by ALINE TABORDA FLESCH (12724983)

Supplementary Material for: Association of Copeptin, a Surrogate Marker of Arginine Vasopressin, with Decreased Kidney Function in Sugarcane Workers in Guatemala by Butler-Dawson J. (8569992)

LdAg-based prophylactic vaccine decreases <i>Leishmania</i> parasitic burden. by Doumet Georges Helou (7255823)

Data_Sheet_2_Mycovirus Fusarium oxysporum f. sp. dianthi Virus 1 Decreases the Colonizing Efficiency of Its Fungal Host.pdf by Almudena Torres-Trenas (6445943)

Data_Sheet_1_Mycovirus Fusarium oxysporum f. sp. dianthi Virus 1 Decreases the Colonizing Efficiency of Its Fungal Host.docx by Almudena Torres-Trenas (6445943)

Decreased temperature increases the expression of a disordered bacterial late embryogenesis abundant (LEA) protein that enhances natural transformation by Terhi Maula (3340797)

Supplementary Material for: Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema by Nunes F.L. (10223465)

Knockdown of Ube2d proteins decreases ubiquitination of EGFR in HeLa cells. by Mariya S. Liyasova (3821908)

All-cause gastroenteritis hospitalisations of children decreased after the introduction of rotavirus vaccine in Stockholm by Selma Olsson-Åkefeldt (11500789)

Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”